Walgreens, Rite Aid Sued by West Virginia Over Opioid Sales
(Bloomberg) -- Walgreens Boots Alliance Inc. and Rite Aid Corp. were sued by West Virginia for allegedly aiding in suspicious sales of addictive opioid drugs through their pharmacies in the state.
The companies knew they were distributing more drugs than medically necessary, and reaped billions of dollars by filling illegal prescriptions from crooked doctors, West Virginia Attorney General Patrick Morrisey said Thursday in a statement. The suits were filed in state court, he said.
“Prescription opioid pill mills and rogue prescribers cannot channel opioids for illicit use without at least the tacit support and willful blindness of distributors, if not their knowing support,” Morrisey said. “Those who unconscionably help create our state's opioid epidemic should be held accountable, pay for their role in the crisis and act to remediate the problem. West Virginia deserves nothing less.”
Both companies distributed drugs to their pharmacies, which also made purchases from other suppliers. From 2006 to 2014, Rite Aid distributed the equivalent of more than 87 million, 10-milligram oxycodone pills, and its retail pharmacies ordered another 127.5 million from others to fulfill demand, Morrisey said. Walgreens distributed the equivalent of 29.6 million pills, and its pharmacies ordered another 17.6 million, the state alleged.
“We never manufactured or marketed opioids, and never sold opioids to the pain clinics, internet pharmacies and ‘pill mills' that fueled the opioid crisis,” Phil Caruso, a Walgreens spokesman, said in a statement. “Prior to 2014, unlike other companies involved in this litigation, we delivered opioids only to our own pharmacies, and the only place we ever sold opioids was at the pharmacy counter, when presented with a prescription written by a prescriber, with a valid DEA license, for a legitimate medical need.”
A spokesman for Rite Aid didn't immediately respond to an emailed request for comment.
Other states and cities have filed similar lawsuits against opioid producers, distributors and pharmacies. West Virginia's opioid death rate in 2017 was three times higher than the U.S. average, according to the lawsuit. The companies were among the state's top 10 distributors of opioids.
©2020 Bloomberg L.P.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.
